- ￥1176 - 9828
- abinScience
- France
- MB186013
- 2026年04月26日
- WB: 1:500-1:2000
- Mouse
- Mouse, Rat
企业认证
相关产品推荐更多 >
](https://img1.dxycdn.com/p/s14/2025/0313/885/8634387850119510091.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 亚型：
IgG2a, kappa
- 形态：
Liquid
- 保存条件：
-20°C
- 克隆性：
单克隆
- 适应物种：
Mouse, Rat
- 保质期：
twelve months
- 级别：
一抗
- 供应商：
武汉益普生物科技有限公司
- 宿主：
Mouse
- 应用范围：
WB: 1:500-1:2000
- 抗体英文名：
Anti-Mouse/Rat KCNA4 Antibody (L71/5R)
- 规格：
50μg/100μg/1mg
| 规格： | 50μg | 产品价格： | ￥1176.0 |
|---|---|---|---|
| 规格： | 100μg | 产品价格： | ￥1956.0 |
| 规格： | 1mg | 产品价格： | ￥9828.0 |
| 产品名 | Anti-Mouse/Rat KCNA4 Antibody (L71/5R) |
| 货号 | MB186013 |
| 宿主 | Mouse |
| 种属反应性 | Mouse, Rat |
| 克隆类型 | Monoclonal |
| 克隆号 | L71/5R |
| Accession号 | Q61423 |
| 靶标 | Voltage-gated potassium channel HBK4, Voltage-gated potassium channel HK1, HPCN2, Voltage-gated K(+) channel HuKII, Potassium voltage-gated channel subfamily A member 4, KCNA4L, KCNA4, Voltage-gated potassium channel subunit Kv1.4 |
| 同种型 | IgG2a, kappa |
| 应用 | IHC, WB |
| 应用范围 | WB: 1:500-1:2000 |
| 内毒素水平 | Please contact with the lab for this information. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| 纯度 | >95% as determined by SDS-PAGE. |
| 状态 | Liquid |
| 保存溶液 | 0.01M PBS, pH 7.4. |
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| 说明 | For research use only. |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验secondary antibody review -- data from 99 publications
Signaling 18 IgG Alexa Fluor 488 immunocytochemistry 1:2000 18 IgG Alexa Fluor 568 immunocytochemistry 1:2000 19 donkey IgG HRP western blot 1:3000 detect antibody binding in mouse epithelial cells Amersham Biosciences 19 goat
Monoclonal Antibody-Based Strategies in Autoimmunity and Transplantation
. Most of the side effects observed with first-generation murine (mouse or rat) antibodies have been successfully overcome with the advent of humanized (chimeric or CDR-grafted) and more recently fully human antibodies. Our aim is to review the major steps in the development
Cloning Single-Chain Antibody Fragments (ScFv) from Hyrbidoma Cells
several limitations of using hybridoma-derived antibodies. The source of the hybridoma clones are mostly rat or mouse B-lymphocytes. Therefore a human-anti-mouse or human-anti-rat antibody response may result in immunogenicity of these antibodies. This leads
技术资料暂无技术资料 索取技术资料
